| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 64.287 | 77.225 | 64.533 | 60.638 | 62.977 | 62.543 | 57.092 | 57.900 | 70.298 | 75.450 |
| Total Income - EUR | 64.287 | 77.225 | 73.293 | 60.643 | 62.982 | 62.548 | 57.102 | 57.900 | 70.298 | 75.450 |
| Total Expenses - EUR | 14.788 | 31.310 | 43.015 | 25.837 | 37.254 | 24.642 | 20.793 | 18.408 | 25.909 | 8.861 |
| Gross Profit/Loss - EUR | 49.499 | 45.914 | 30.277 | 34.806 | 25.728 | 37.906 | 36.310 | 39.492 | 44.389 | 66.589 |
| Net Profit/Loss - EUR | 47.570 | 44.370 | 29.632 | 34.248 | 25.099 | 37.281 | 35.089 | 37.755 | 43.686 | 64.326 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Us Diagnosis 2013 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 120 | 785 | 488 | 240 | 532 | 394 | 260 | 136 | 10 | 0 |
| Current Assets | 72.498 | 57.454 | 42.638 | 46.577 | 62.778 | 74.393 | 72.390 | 52.885 | 13.158 | 6.378 |
| Inventories | 1.105 | 1.639 | 42 | 41 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 932 | 7.420 | 13.440 | 13.305 | 5.003 | 5.316 | 10.786 | 8.342 | 4.043 | 3.672 |
| Cash | 70.461 | 48.395 | 29.157 | 33.231 | 57.776 | 69.076 | 61.603 | 44.542 | 9.115 | 2.706 |
| Shareholders Funds | 10.907 | 10.796 | 10.613 | 36.715 | 36.004 | 35.322 | 69.627 | 47.834 | 15.883 | 3.411 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 61.711 | 47.443 | 32.513 | 10.102 | 27.306 | 39.465 | 3.023 | 5.186 | -2.715 | 2.967 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Us Diagnosis 2013 Srl